Skip to main content
. 2019 Sep 10;18(5):4691–4702. doi: 10.3892/ol.2019.10846

Figure 4.

Figure 4.

Kaplan-Meier OS curves of LIHC patients in different conditions comparing peptidyl-prolyl cis-trans isomerase A high and low expression levels by Kaplan-Meier Plotter. The liver hepatocellular carcinoma OS curves of (A) stage 3, (B) AJCC T3, (C) HBV negative and (D) sorafenib-administered subgroups respectively. OS, overall survival; HBV, hepatitis B virus; HR, hazard ratio.